MAPS Act

The MAPS Act requires the Secretary of Health and Human Services to update and maintain an Essential Medicines List including drugs critical for national security, public health emergencies, chronic conditions, and military readiness. It mandates annual risk assessments identifying supply chain vulnerabilities, particularly drugs sourced over 50% from high-risk foreign suppliers like China, and compiles data on manufacturing locations and shortages. The bill directs HHS to map U.S. pharmaceutical supply chains from raw materials to finished products, using data analytics to identify national security threats, and report findings annually to Congress. This directly affects federal agencies (HHS, Defense), drug manufacturers, and supply chain stakeholders through mandatory reporting and transparency requirements.